Finance

Lists
ALTHX:EPA
Thx Pharma SA
₮3,20
-1,99%
(-0,065) 1D
17 āšž.āšˆ., 12 āŧ‚āšĄāš‡ 45 āš™āšēāš—āšĩ 23 āš§āšīāš™āšēāš—āšĩ GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ALTHX...
Open
₮3,25
High
₮3,26
Low
₮3,18
Mkt. cap
46,39 āšĨāŧ‰āšēāš™
Avg. vol.
43,62Â āšžāšąāš™
Volume
15,28Â āšžāšąāš™
52-wk high
₮5,10
52-wk low
₮1,49
EPS
₮-0,22
Shares outstanding
14,47 āšĨāŧ‰āšēāš™
No. of employees
12
Open
₮3,25
High
₮3,26
Low
₮3,18
Mkt. cap
46,39 āšĨāŧ‰āšēāš™
Avg. vol.
43,62Â āšžāšąāš™
Volume
15,28Â āšžāšąāš™
52-wk high
₮5,10
52-wk low
₮1,49
EPS
₮-0,22
Shares outstanding
14,47 āšĨāŧ‰āšēāš™
No. of employees
12
News stories
From web sources and news partners
qz.com
qz.com
·
16 āš™āšēāš—āšĩāšāŧˆāš­āš™
5 Nasdaq-linked stock indexes and how each differs from the S&P 500
The Motley Fool
The Motley Fool
·
1 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
Will Your S&P 500 Index Fund Be Forced to Buy Anthropic? Here’s What the Rules Say.
Trefis
Trefis
·
4 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
31 S&P 500 Stocks Just Made New 52-Week Highs
Traders Union
Traders Union
·
13 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
About Thx Pharma SA
CEO-
Employees12
Founded2013
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
āš.āš. 2025
āš—.āš§. 2025
āšĄ.āš™. 2026
āšĄāšī.āš–. 2026
Revenue
1,00
1,00
1,63 āšĨāŧ‰āšēāš™
1,63 āšĨāŧ‰āšēāš™
Cost of goods sold
627,08Â āšžāšąāš™
627,08Â āšžāšąāš™
1,08 āšĨāŧ‰āšēāš™
1,08 āšĨāŧ‰āšēāš™
Cost of revenue
627,08Â āšžāšąāš™
627,08Â āšžāšąāš™
1,08 āšĨāŧ‰āšēāš™
1,08 āšĨāŧ‰āšēāš™
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
479,04Â āšžāšąāš™
479,04Â āšžāšąāš™
863,29Â āšžāšąāš™
863,29Â āšžāšąāš™
Operating expense
821,69Â āšžāšąāš™
821,69Â āšžāšąāš™
919,46Â āšžāšąāš™
919,46Â āšžāšąāš™
Total operating expenses
1,45 āšĨāŧ‰āšēāš™
1,45 āšĨāŧ‰āšēāš™
2,00 āšĨāŧ‰āšēāš™
2,00 āšĨāŧ‰āšēāš™
Operating income
-1,45 āšĨāŧ‰āšēāš™
-1,45 āšĨāŧ‰āšēāš™
-374,50Â āšžāšąāš™
-374,50Â āšžāšąāš™
Other non operating income
-2,74Â āšžāšąāš™
-2,74Â āšžāšąāš™
2,64Â āšžāšąāš™
2,64Â āšžāšąāš™
EBT including unusual items
-1,42 āšĨāŧ‰āšēāš™
-1,42 āšĨāŧ‰āšēāš™
-314,38Â āšžāšąāš™
-314,38Â āšžāšąāš™
EBT excluding unusual items
-1,42 āšĨāŧ‰āšēāš™
-1,42 āšĨāŧ‰āšēāš™
-307,91Â āšžāšąāš™
-307,91Â āšžāšąāš™
Income tax expense
-458,91Â āšžāšąāš™
-458,91Â āšžāšąāš™
-264,18Â āšžāšąāš™
-264,18Â āšžāšąāš™
Effective tax rate
32,23%
32,23%
84,03%
84,03%
Other operating expenses
312,66Â āšžāšąāš™
312,66Â āšžāšąāš™
26,90Â āšžāšąāš™
26,90Â āšžāšąāš™
Net income
-964,82Â āšžāšąāš™
-964,82Â āšžāšąāš™
-50,19Â āšžāšąāš™
-50,19Â āšžāšąāš™
Net profit margin
-96.482.400,00%
-96.482.400,00%
-3,08%
-3,08%
Earnings per share
-
-
-
-
Interest and investment income
32,02Â āšžāšąāš™
32,02Â āšžāšąāš™
92,74Â āšžāšąāš™
92,74Â āšžāšąāš™
Interest expense
-23,76Â āšžāšąāš™
-23,76Â āšžāšąāš™
-24,97Â āšžāšąāš™
-24,97Â āšžāšąāš™
Net interest expenses
8,27Â āšžāšąāš™
8,27Â āšžāšąāš™
67,77Â āšžāšąāš™
67,77Â āšžāšąāš™
Depreciation and amortization charges
29,99Â āšžāšąāš™
29,99Â āšžāšąāš™
29,27Â āšžāšąāš™
29,27Â āšžāšąāš™
EBITDA
-1,42 āšĨāŧ‰āšēāš™
-1,42 āšĨāŧ‰āšēāš™
-345,23Â āšžāšąāš™
-345,23Â āšžāšąāš™
Gain or loss from assets sale
-55,61Â āšžāšąāš™
-55,61Â āšžāšąāš™
-29,43Â āšžāšąāš™
-29,43Â āšžāšąāš™
Upcoming events
AI content may include mistakes. Learn more
āŧāš­āšąāššāš‚āš­āš‡ Google